Study of the indications for macrolide prescriptions in a Colombian population
Abstract
Introduction: The inappropriate use of antibiotics is associated with a greater risk for antimicrobial resistance, high health care costs, adverse events, and worse clinical outcomes.
Objective: To determine the prescription patterns and approved and nonapproved indications for macrolides in a group of patients from Colombia.
Materials and methods: This was a cross-sectional study on the indications for the use of macrolides in outpatients registered in a drug-dispensing database of approximately 8.5 million people affiliated with the Colombian health system. Sociodemographic, pharmacological, and clinical variables were considered.
Results: A total of 9.344 patients had received a macrolide prescription; their median age was 40.1 years (interquartile range: 27.1-53.3 years) and 58.3% were women. The most commonly prescribed macrolide was azithromycin (38.8%) most frequently for Helicobacter pylori infection (15.9%) and pneumonia treatment (15.8%). A total of 31.3% of the prescriptions were used for unapproved indications: common cold (7.8%), COVID-19 (4.0%), and acute bronchitis (3.5%). Residence in the Caribbean region (OR=1.17; 95%CI 1.05-1.31), dental prescriptions (OR=2.75; 95%CI 1.91-3.96), presence of chronic respiratory comorbidities (OR=1.30; 95%CI 1.08-1.56), and prescription of erythromycin (OR=3.66; 95%CI 3.24-4.14) or azithromycin (OR=2.15; 95%CI 1,92-2.41) were associated with a higher probability of macrolide use for unapproved indications while being 18-64 years old (OR=0.81; 95%CI 0.71-0.93) or 65 years or older (OR=0.77; 95%CI 0.63-0.94) and residing in Bogotá-Cundinamarca (OR=0.74; 95%CI 0.65-0.85) were associated with reduced risk.
Conclusions: Most patients received macrolides for respiratory tract infections; erythromycin and azithromycin were used for unapproved indications in people under 18 years of age and those with chronic respiratory diseases.
Downloads
References
Chang Y, Chusri S, Sangthong R, McNeil E, Hu J, Du W, et al. Clinical pattern of antibiotic overuse and misuse in primary healthcare hospitals in the southwest of China. PloS ONE. 2019;14:e0214779. https://doi.org/10.1371/journal.pone.0214779
Li J, Song X, Yang T, Chen Y, Gong Y, Yin X, et al. A systematic review of antibiotic prescription associated with upper respiratory tract infections in China. Medicine. 2016;95:e3587. https://doi.org/10.1097/MD.0000000000003587
Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, et al. Antibiotic resistance: A rundown of a global crisis. Infec Drug Resist. 2018;11:1645-58. https://doi.org/10.2147/IDR.S173867
Pokharel S, Raut S, Adhikari B. Tackling antimicrobial resistance in low-income and middleincome countries. BMJ Global Health. 2019;4:e002104. http://dx.doi.org/10.1136/bmjgh-2019-002104
World Health Organization (WHO). The world health report 2007. A safer future: Global public health security in the 21st century. Geneva: World Health Organization; 2007. Fecha de consulta: 1 de abril de 2021. Disponible en: https://www.who.int/whr/2007/en/
Sulis G, Adam P, Nafade V, Gore G, Daniels B, Daftary A, et al. Antibiotic prescription practices in primary care in low- and middle-income countries: A systematic review and meta-analysis. PLoS Medicine. 2020;17:e1003139. https://doi.org/10.1371/journal.pmed.1003139
Butt AA, Navasero CS, Thomas B, Marri SA, Katheeri HA, Thani AA, et al. Antibiotic prescription patterns for upper respiratory tract infections in the outpatient Qatari population in the private sector. Int J Infect Dis. 2017;55:20-3. https://doi.org/10.1016/j.ijid.2016.12.004
Gebeyehu E, Bantie L, Azage M. Inappropriate use of antibiotics and its associated factors among urban and rural communities of Bahir Dar City Administration, Northwest Ethiopia. PloS ONE. 2015;10:e0138179. https://doi.org/10.1371/journal.pone.0138179
Hicks LA, Bartoces MG, Roberts RM, Suda KJ, Hunkler RJ, Taylor TH Jr., et al. US outpatient antibiotic prescribing variation according to geography, patient population, and provider specialty in 2011. Clin Infect Dis. 2015;60:1308-16. https://doi.org/10.1093/cid/civ076
Hashimoto H, Matsui H, Sasabuchi Y, Yasunaga H, Kotani K, Nagai R, et al. Antibiotic prescription among outpatients in a prefecture of Japan, 2012-2013: A retrospective claims database study. BMJ Open. 2019;9:e026251. https://doi.org/10.1136/bmjopen-2018-026251
Machado-Alba JE, Valladales-Restrepo LF, Gaviria-Mendoza A, Machado-Duque ME, Figueras A. Patterns of antibiotic prescription in Colombia: Are there differences between capital cities and municipalities? Antibiotics. 2020;9. https://doi.org/10.3390/antibiotics9070389
Dinos GP. The macrolide antibiotic renaissance. Br J Pharmacol. 2017;174:2967-83. https://doi.org/10.1111/bph.13936
World Health Organization (WHO). WHO Collaborating Centre for Drugs Statistics Methodology. Fecha de consulta: 30 de noviembre de 2020. Disponible en: http://www.whocc.no/atc_ddd_index/
Micromedex, Inc. Clarithromycin. En: Drug Point Summary [database on the Internet]. Greenwood Village (CO): IBM Corporation; 2021. Fecha de consulta: 8 de enero de 2021. Disponible en: www.micromedexsolutions.com
Micromedex, Inc. Erythromycin. En: Drug Point Summary [database on the Internet]. Greenwood Village (CO): IBM Corporation; 2021. Fecha de consulta: 8 de enero de 2021. Disponible en: www.micromedexsolutions.com
Micromedex, Inc. Azithromycin. En: Drug Point Summary [database on the Internet]. Greenwood Village (CO): IBM Corporation; 2021. Fecha de consulta: 8 de enero de 2021. Disponible en: www.micromedexsolutions.com
Micromedex, Inc. Spiramycin. En: Drug Point Summary [database on the Internet]. Greenwood Village (CO): IBM Corporation; 2021. Fecha de consulta: 8 de enero de 2021. Disponible en: www.micromedexsolutions.com
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA). Consulta de datos de productos. Fecha de consulta: 7 marzo de 2022. Disponible en: http://consultaregistro.invima.gov.co/Consultas/consultas/consreg_encabcum.jsp
Valderrama-Beltrán S, Cortés JA, Caro MA, Cely-Andrade L, Osorio-Pinzón JV, Gualtero SM, et al. Guía de práctica clínica para el diagnóstico y manejo de las infecciones de piel y tejidos blandos en Colombia. Infectio. 2019;23:318-46. https://doi.org/10.22354/in.v23i4.805
Sánchez-Huesca R, Lerma A, Guzmán-Saldaña RME, Lerma C. Prevalence of antibiotics prescription and assessment of prescribed daily dose in outpatients from Mexico City. Antibiotics. 2020;9:38. https://doi.org/10.3390/antibiotics9010038
Sánchez-Choez X, Armijos-Acurio ML, Jimbo-Sotomayor RE. Appropriateness and adequacy of antibiotic prescription for upper respiratory tract infections in ambulatory health care centers in Ecuador. BMC Pharmacol Toxicol. 2018;19:46. https://doi.org/10.1186/s40360-018-0237-y
Rezal RS, Hassali MA, Alrasheedy AA, Saleem F, Yusof FA, Kamal M, et al. Prescribing patterns for upper respiratory tract infections: A prescription-review of primary care practice in Kedah, Malaysia, and the implications. Expert Rev Anti Infect Ther. 2015;13:1547-56. https://doi.org/10.1586/14787210.2015.1085303
Aljadeeah S, Wirtz VJ, Nagel E. Outpatient antibiotic dispensing for the population with government health insurance in Syria in 2018-2019. Antibiotics. 2020;9. https://doi.org/10.3390/antibiotics9090570
Islam MA, Akhtar Z, Hassan MZ, Chowdhury S, Rashid MM, Aleem MA, et al. Pattern of antibiotic dispensing at pharmacies according to the WHO Access, Watch, Reserve (AWaRe) classification in Bangladesh. Antibiotics (Basel). 2022;11:247. https://doi.org/10.3390/antibiotics11020247
King LM, Lovegrove MC, Shehab N, Tsay S, Budnitz DS, Geller AI, et al. Trends in US outpatient antibiotic prescriptions during the Coronavirus Disease 2019 pandemic. Clin Infect Dis. 2021;73:e652-60. https://doi.org/10.1093/cid/ciaa1896
Adriaenssens N, Bruyndonckx R, Versporten A, Hens N, Monnet DL, Molenberghs G, et al. Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997-2017. J Antimicrob Chemother. 2021;76(Suppl.2):ii2-ii6. https://doi.org/10.1093/jac/dkab175
Al-Azzam S, Mhaidat NM, Banat HA, Alfaour M, Ahmad DS, Muller A, et al. An assessment of the impact of Coronavirus Disease (COVID-19) pandemic on national antimicrobial consumption in Jordan. Antibiotics (Basel). 2021;10:690. https://doi.org/10.3390/antibiotics10060690
Hussain AZ, Paudyal V, Hadi MA. Impact of the COVID-19 pandemic on the prescribing patterns of first-line antibiotics in English primary care: A longitudinal analysis of national prescribing dataset. Antibiotics (Basel). 2021;10:591. https://doi.org/10.3390/antibiotics10050591
Buehrle DJ, Wagener MM, Nguyen MH, Clancy CJ. Trends in outpatient antibiotic prescriptions in the United States during the COVID-19 pandemic in 2020. JAMA Network Open. 2021;4:e2126114-e. https://doi:10.1001/jamanetworkopen.2021.26114
Ministerio de Salud y Protección Social, Colombia. Resolución 3512 de 2019, Actualización Plan de Beneficios. Fecha de consulta: 7 de marzo de 2022. Disponible en: https://www.minsalud.gov.co/salud/POS/Paginas/plan-obligatorio-de-salud-pos.aspx
Doorakkers E, Lagergren J, Gajulapuri VK, Callens S, Engstrand L, Brusselaers N. Helicobacter pylori eradication in the Swedish population. Scand J Gastroenterol. 2017;52:678-85. https://doi.org/10.1080/00365521.2017.1303844
Cohen SS, Alexander DD, Krebs NF, Young BE, Cabana MD, Erdmann P, et al. Factors associated with breastfeeding initiation and continuation: A meta-analysis. J Pediatr. 2018;203:190-6.e21. https://doi.org/10.1016/j.jpeds.2018.08.008
Gómez M, Otero W, Gutiérrez Ó. Tratamiento de la infección por Helicobacter pylori. Encuesta en un grupo de médicos generales y especialistas en Colombia. Rev Colomb Gastroenterol. 2007;22:7-16.
Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut. 2017;66:6-30. https://doi.org/10.1136/gutjnl-2016-312288
Martínez-García M, Máiz L, Olveira C, Girón RM, de la Rosa D, Blanco M, et al. Spanish Guidelines on treatment of bronchiectasis in adults. Arch Bronconeumol (Engl Ed). 2018;54:88-98. https://doi.org/10.1016/j.arbres.2017.07.016
Sánchez GV, Shapiro DJ, Hersh AL, Hicks LA, Fleming-Dutra KE. Outpatient macrolide antibiotic prescribing in the United States, 2008-2011. Open Forum Infect Dis. 2017;4:ofx220-ofx. https://doi.org/10.1093/ofid/ofx220
Montufar F, Álvarez C, Giraldo-Cadavid L, Aguirre C, Varón F, Ali Munive A. Recomendaciones para el diagnóstico, tratamiento y prevención de la neumonía adquirida en la comunidad en adultos inmunocompetentes. Infectio. 2013;17:1-38. https://doi.org/10.1016/S0123-9392(13)70019-5
Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45-e67. https://doi.org/10.1164/rccm.201908-1581ST
Harris M, Clark J, Coote N, Fletcher P, Harnden A, McKean M, et al. British Thoracic Society guidelines for the management of community-acquired pneumonia in children: Update 2011. Thorax. 2011;66(Suppl.2):ii1-23. https://doi.org/10.1136/thoraxjnl-2011-200598
Shively NR, Buehrle DJ, Clancy CJ, Decker BK. Prevalence of inappropriate antibiotic prescribing in primary care clinics within a veterans affairs health care system. Antimicrob Agents Chemother. 2018;62:e00337-18. https://doi.org/10.1128/AAC.00337-18
Saleem Z, Saeed H, Hassali MA, Godman B, Asif U, Yousaf M, et al. Pattern of inappropriate antibiotic use among hospitalized patients in Pakistan: A longitudinal surveillance and implications. Antimicrob Resist Infect Control. 2019;8:188. https://doi.org/10.1186/s13756-019-0649-5
Calderón-Parra J, Muiño-Miguez A, Bendala-Estrada AD, Ramos-Martínez A, Muñez-Rubio E, Fernández-Carracedo E, et al. Inappropriate antibiotic use in the COVID-19 era: Factors associated with inappropriate prescribing and secondary complications. Analysis of the registry SEMI-COVID. PloS ONE. 2021;16:e0251340.
https://doi.org/10.1371/journal.pone.0251340
Bianco A, Papadopoli R, Mascaro V, Pileggi C, Pavia M. Antibiotic prescriptions to adults with acute respiratory tract infections by Italian general practitioners. J Glob Antimicrob Resist. 2018;11:2199-205. https://doi.org/10.2147/IDR.S170349
Machado-Duque M, Mercado-Gómez K, Bernal-Chica M, Uribe-Vélez S, Machado-Alba J. Prescripción e indicaciones de uso de fluoroquinolonas en un grupo de pacientes ambulatorios de Colombia. Biomédica. 2020;40:382-90. https://doi.org/10.7705/biomedica.5103
Valladales-Restrepo LF, Constain-Mosquera CA, Álvarez-Amaya V, Machado-Alba JE. Study of prescription-indication of tetracyclines in a population in Colombia. Fundam Clin Pharmacol. 2021;36:390-6. https://doi.org/10.1111/fcp.12724
Nowakowska M, van Staa T, Mölter A, Ashcroft DM, Tsang JY, White A, et al. Antibiotic choice in UK general practice: Rates and drivers of potentially inappropriate antibiotic prescribing. J. Antimicrob. Chemother. 2019;74:3371-8. https://doi.org/10.1093/jac/dkz345
Fashner J, Ericson K, Werner S. Treatment of the common cold in children and adults. Am Fam Physician. 2012;86:153-9.
Gautret P, Lagier J-C, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. 2020;56:105949. https://doi.org/10.1016/j.ijantimicag.2020.105949
Verdejo C, Vergara-Merino L, Meza N, Pérez-Bracchiglione J, Carvajal-Juliá N, Madrid E, et al. Macrolides for the treatment of COVID-19: A living, systematic review. Medwave. 2020;20:e8074. https://doi.org/10.5867/medwave.2020.11.8073
Estrada-Orozco K, Saavedra C. Manejo del paciente con infección por SARS-CoV-2/COVID-19. Infectio. 2021;25(Supl.1):78-123. https://doi.org/10.22354/in.v25i4.975
Bonaldo G, Andriani LA, D’Annibali O, Motola D, Vaccheri A. Cardiovascular safety of macrolide and fluoroquinolone antibiotics: An analysis of the WHO database of adverse drug reactions. Pharmacoepidemiol Drug Saf. 2019;28:1457-63. https://doi.org/10.1002/pds.4873
Vandael E, Vandenberk B, Vandenberghe J, Spriet I, Willems R, Foulon V. Development of a risk score for QTc-prolongation: The RISQ-PATH study. Int J Clin Pharm. 2017;39:424-32. https://doi.org/10.1007/s11096-017-0446-2
Global Strategy for Asthma Management and Prevention. 2021 GINA Report, Global Strategy for Asthma Management and Prevention. Fecha de consulta: 9 de enero de 2021. Disponible en: https://ginasthma.org/
Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease; 2021. Fecha de consulta: 9 de enero de 2021. Disponible en: https://ginasthma.org/gina-reports/
Siqueira JF, Rôças IN. Microbiology and treatment of acute apical abscesses. Clin Microbiol Rev. 2013;26:255-73. https://doi.org/10.1128/CMR.00082-12
Shweta, Prakash SK. Dental abscess: A microbiological review. Dent Res J (Isfahan). 2013;10:585-91.
Jevon P, Abdelrahman A, Pigadas N. Management of odontogenic infections and sepsis: An update. Br Dent J. 2020;229:363-70. https://doi.org/10.1038/s41415-020-2114-5
Some similar items:
- Jorge E. Machado-Alba, Luis Felipe Echeverri-Cataño, Manuel José Londoño-Builes, Paula Andrea Moreno-Gutiérrez, Sergio Andrés Ochoa-Orozco, Joaquín Octavio Ruiz-Villa, Social, cultural and economic factors associated with self-medication , Biomedica: Vol. 34 No. 4 (2014)
- Juan Pablo Orozco-Hernández , Juan José Montoya-Martínez, Manuel Conrado Pacheco-Gallego, Mauricio Céspedes-Roncancio , Gloria Liliana Porras-Hurtado, SARS-CoV-2 and rhinovirus/enterovirus co-infection in a critically ill young adult patient in Colombia , Biomedica: Vol. 40 No. Supl. 2 (2020): SARS-CoV-2 y COVID-19
- Manuel Enrique Machado-Duque, Catalina Alzate-Carvajal, Kevin Zapata-Castañeda, Jorge Enrique Machado-Alba, Profile of lithium carbonate use in patients with bipolar disorder in Colombia , Biomedica: Vol. 37 No. Sup.1 (2017): Suplemento 1, Alteraciones del sistema nervioso
- Claudia Calderón, Rodolfo Dennis, Economic cost of Streptococcus pneumoniae community-acquired pneumonia, meningitis and bacteremia in an adult population that required hospitalization in Bogotá, Colombia , Biomedica: Vol. 34 No. 1 (2014)
- Patricia Escandón, Shawn R. Lockhart, Nancy A. Chow, Tom M. Chiller, Candida auris: a global pathogen that has taken root in Colombia , Biomedica: Vol. 43 No. Sp. 1 (2023): Agosto, Micología médica
- Jorge Enrique Machado-Alba, Luis Felipe Calvo-Torres, Andrés Gaviria-Mendoza, Juan Daniel Castrillón-Spitia, Prescribing patterns of antiparkinson drugs in a group of Colombian patients, 2015 , Biomedica: Vol. 38 No. 3 (2018)
- Jorge E. Machado-Alba, Cristhian David Morales-Plaza, Antipsychotic prescription patterns in patients affiliated to the Social Security Health System in Colombia , Biomedica: Vol. 33 No. 3 (2013)
- Elizabeth Borrero, Gabriel Carrasquilla, Neal Alexander, Decentralization and health system reform: What is their impact on malaria incidence in Colombian municipalities? , Biomedica: Vol. 32 (2012): Suplemento 1, Malaria
- Giovanny Montoya, Claudia Vaca, María Fernanda Parra, Adverse events associated with tramadol and dipirona administration in a level III hospital , Biomedica: Vol. 29 No. 3 (2009)
- Andrés Páez, Gloria Rey, Carlos Agudelo, Alvaro Dulce, Edgar Parra, Hernando Díaz-Granados, Damaris Heredia, Luis Polo, Outbreak of urban rabies transmitted by dogs in Santa Marta, northern Colombia , Biomedica: Vol. 29 No. 3 (2009)
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
